Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin)

INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes ...

Related Keywords

United States ,Texas ,Americans ,American ,America ,Carrie Siragusa ,Craig Granowitz ,American College Of Cardiology ,American Heart Association ,Heart Failure Society Of America ,Science Session Of The American Heart Association ,Lexicon Pharmaceuticals ,Nasdaq ,Exchange Commission ,Drug Administration ,Lexicon Pharmaceuticals Inc ,Lonnel Coats ,Worsening Heart Failure ,American College ,Heart Failure Society ,Guideline Directed Medical Therapy ,Concomitant Use ,Insulin Secretagogues ,Mycotic Infections ,Glucose Test ,Adverse Reactions ,Specific Populations ,Late Breaking Science Session ,Scientific Sessions ,New England Journal ,Recent Worsening Heart Failure ,Chronic Kidney Disease ,Investor Inquiries ,Nasdaq Lxrx ,Nc ,